356 related articles for article (PubMed ID: 12734345)
41. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.
Taams LS; Smith J; Rustin MH; Salmon M; Poulter LW; Akbar AN
Eur J Immunol; 2001 Apr; 31(4):1122-31. PubMed ID: 11298337
[TBL] [Abstract][Full Text] [Related]
42. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
Qiao M; Thornton AM; Shevach EM
Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
[TBL] [Abstract][Full Text] [Related]
43. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
[TBL] [Abstract][Full Text] [Related]
44. Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma.
Cauley LS; Miller EE; Yen M; Swain SL
J Immunol; 2000 Dec; 165(11):6056-66. PubMed ID: 11086037
[TBL] [Abstract][Full Text] [Related]
45. Activation-mediated CD4+ T cell unresponsiveness during acute Toxoplasma gondii infection in mice.
Khan IA; Matsuura T; Kasper LH
Int Immunol; 1996 Jun; 8(6):887-96. PubMed ID: 8671678
[TBL] [Abstract][Full Text] [Related]
46. The accumulation of B220+ CD4- CD8- (DN) T cells in C3H-lpr/lpr mice is not accelerated by the stimulation of CD8+ T cells or B220+ DN T cells with staphylococcal enterotoxin B and occurs independently of V beta 8+ T cells.
Giese T; Davidson WF
Int Immunol; 1995 Aug; 7(8):1213-23. PubMed ID: 7495728
[TBL] [Abstract][Full Text] [Related]
47. Superantigens anergize cytokine production but not cytotoxicity in vivo.
Sundstedt A; Dohlsten M; Hedlund G; Höidén I; Björklund M; Kalland T
Immunology; 1994 May; 82(1):117-25. PubMed ID: 7913912
[TBL] [Abstract][Full Text] [Related]
48. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen.
Thorstenson KM; Khoruts A
J Immunol; 2001 Jul; 167(1):188-95. PubMed ID: 11418648
[TBL] [Abstract][Full Text] [Related]
49. Lung CD25 CD4 regulatory T cells suppress type 2 immune responses but not bronchial hyperreactivity.
Hadeiba H; Locksley RM
J Immunol; 2003 Jun; 170(11):5502-10. PubMed ID: 12759427
[TBL] [Abstract][Full Text] [Related]
50. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells.
Zheng SG; Wang JH; Stohl W; Kim KS; Gray JD; Horwitz DA
J Immunol; 2006 Mar; 176(6):3321-9. PubMed ID: 16517699
[TBL] [Abstract][Full Text] [Related]
51. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].
Taylor PA; Lees CJ; Fournier S; Allison JP; Sharpe AH; Blazar BR
J Immunol; 2004 Jan; 172(1):34-9. PubMed ID: 14688306
[TBL] [Abstract][Full Text] [Related]
52. CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.
Casares N; Arribillaga L; Sarobe P; Dotor J; Lopez-Diaz de Cerio A; Melero I; Prieto J; Borrás-Cuesta F; Lasarte JJ
J Immunol; 2003 Dec; 171(11):5931-9. PubMed ID: 14634104
[TBL] [Abstract][Full Text] [Related]
53. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells.
Vahlenkamp TW; Tompkins MB; Tompkins WA
J Immunol; 2004 Apr; 172(8):4752-61. PubMed ID: 15067051
[TBL] [Abstract][Full Text] [Related]
54. An essential role for Scurfin in CD4+CD25+ T regulatory cells.
Khattri R; Cox T; Yasayko SA; Ramsdell F
Nat Immunol; 2003 Apr; 4(4):337-42. PubMed ID: 12612581
[TBL] [Abstract][Full Text] [Related]
55. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.
Fantini MC; Becker C; Monteleone G; Pallone F; Galle PR; Neurath MF
J Immunol; 2004 May; 172(9):5149-53. PubMed ID: 15100250
[TBL] [Abstract][Full Text] [Related]
56. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells.
Piccirillo CA; Shevach EM
J Immunol; 2001 Aug; 167(3):1137-40. PubMed ID: 11466326
[TBL] [Abstract][Full Text] [Related]
57. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.
Levings MK; Sangregorio R; Roncarolo MG
J Exp Med; 2001 Jun; 193(11):1295-302. PubMed ID: 11390436
[TBL] [Abstract][Full Text] [Related]
58. Cutting edge: cell autonomous rather than environmental factors control bacterial superantigen-induced T cell anergy in vivo.
Attinger A; Acha-Orbea H; MacDonald HR
J Immunol; 2000 Aug; 165(3):1171-4. PubMed ID: 10903713
[TBL] [Abstract][Full Text] [Related]
59. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.
Steinbrink K; Graulich E; Kubsch S; Knop J; Enk AH
Blood; 2002 Apr; 99(7):2468-76. PubMed ID: 11895781
[TBL] [Abstract][Full Text] [Related]
60. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.
Fehérvári Z; Sakaguchi S
Int Immunol; 2004 Dec; 16(12):1769-80. PubMed ID: 15520045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
